These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 7742525)
21. The evaluation of red blood cell folate and methotrexate levels during protocol M in childhood acute lymphoblastic leukemia. Oosterom N; Fiocco M; Kloos RQH; van der Sluis IM; Pieters R; van Zelst BD; Smith DEC; van den Heuvel-Eibrink MM; de Jonge R; Heil SG BMC Cancer; 2020 Sep; 20(1):940. PubMed ID: 32998716 [TBL] [Abstract][Full Text] [Related]
22. Evidence for a functional defect in the translocation of the methotrexate transport carrier in a methotrexate-resistant murine L1210 leukemia cell line. Schuetz JD; Matherly LH; Westin EH; Goldman ID J Biol Chem; 1988 Jul; 263(20):9840-7. PubMed ID: 2838483 [TBL] [Abstract][Full Text] [Related]
23. Cross-resistance studies of folylpolyglutamate synthetase-deficient, methotrexate-resistant CCRF-CEM human leukemia sublines. McGuire JJ; Heitzman KJ; Haile WH; Russell CA; McCloskey DE; Piper JR Leukemia; 1993 Dec; 7(12):1996-2003. PubMed ID: 8255099 [TBL] [Abstract][Full Text] [Related]
24. Trimetrexate inhibits progression of the murine 32Dp210 model of chronic myeloid leukemia in animals expressing drug-resistant dihydrofolate reductase. Sweeney CL; Frandsen JL; Verfaillie CM; McIvor RS Cancer Res; 2003 Mar; 63(6):1304-10. PubMed ID: 12649191 [TBL] [Abstract][Full Text] [Related]
25. Trimetrexate as biochemical modulator of 5-fluorouracil/leucovorin in advanced colorectal cancer: final results of a randomised European study. Punt CJ; Keizer HJ; Douma J; Skovsgaard T; Schüller J; Muller EW; Ten Napel CH; Croles JJ; Lochs H; Zhang J; Hammershaimb L Ann Oncol; 2002 Jan; 13(1):81-6. PubMed ID: 11865814 [TBL] [Abstract][Full Text] [Related]
26. Impact of SLCO1B1 521T > C variant on leucovorin rescue and risk of relapse in childhood acute lymphoblastic leukemia treated with high-dose methotrexate. Zhang HN; He XL; Wang C; Wang Y; Chen YJ; Li JX; Niu CH; Gao P Pediatr Blood Cancer; 2014 Dec; 61(12):2203-7. PubMed ID: 25130190 [TBL] [Abstract][Full Text] [Related]
28. Thymidylate synthase as a target for growth inhibition in methotrexate-sensitive and -resistant human head and neck cancer and leukemia cell lines. McGuire JJ; Magee KJ; Russell CA; Canestrari JM Oncol Res; 1997; 9(3):139-47. PubMed ID: 9220499 [TBL] [Abstract][Full Text] [Related]
30. Establishment of methotrexate-resistant human acute lymphoblastic leukemia cells in culture and effects of folate antagonists. Ohnoshi T; Ohnuma T; Takahashi I; Scanlon K; Kamen BA; Holland JF Cancer Res; 1982 May; 42(5):1655-60. PubMed ID: 6978176 [TBL] [Abstract][Full Text] [Related]
31. Folate requirements of methotrexate-resistant human acute lymphoblastic leukemia cell lines. Kano Y; Ohnuma T; Holland JF Blood; 1986 Aug; 68(2):586-91. PubMed ID: 2942201 [TBL] [Abstract][Full Text] [Related]
32. The basis for intrinsic drug resistance or sensitivity to methotrexate. Bertino JR; Lin J; Pizzorno G; Li WW; Chang YM Adv Enzyme Regul; 1989; 29():277-85. PubMed ID: 2633614 [TBL] [Abstract][Full Text] [Related]
33. N10-propargyl-5,8-dideazafolic acid (CB3717): inhibitory effects on human leukemia cell lines resistant to methotrexate or trimetrexate. Takemura Y; Ohnuma T Mt Sinai J Med; 1992 Oct; 59(5):419-24. PubMed ID: 1435841 [TBL] [Abstract][Full Text] [Related]
34. High leucovorin doses during high-dose methotrexate treatment may reduce the cure rate in childhood acute lymphoblastic leukemia. Skärby TV; Anderson H; Heldrup J; Kanerva JA; Seidel H; Schmiegelow K; Leukemia; 2006 Nov; 20(11):1955-62. PubMed ID: 16990760 [TBL] [Abstract][Full Text] [Related]
35. Patient-derived oral mucosa organoids as an in vitro model for methotrexate induced toxicity in pediatric acute lymphoblastic leukemia. Driehuis E; Oosterom N; Heil SG; Muller IB; Lin M; Kolders S; Jansen G; de Jonge R; Pieters R; Clevers H; van den Heuvel-Eibrink MM PLoS One; 2020; 15(5):e0231588. PubMed ID: 32421698 [TBL] [Abstract][Full Text] [Related]
36. Trimetrexate: review and current clinical experience in advanced colorectal cancer. Blanke CD; Messenger M; Taplin SC Semin Oncol; 1997 Oct; 24(5 Suppl 18):S18-57-S18-63. PubMed ID: 9420022 [TBL] [Abstract][Full Text] [Related]
37. Reversal of methotrexate cytotoxicity to human bone marrow cells and leukemic K562 cells by leucovorin: methotrexate polyglutamates formation as a possible important factor. Koizumi S; Ueno Y; Ohno I; Ichihara T; Tamaru Y; Matsukawa H Jpn J Cancer Res; 1990 Nov; 81(11):1162-7. PubMed ID: 1702414 [TBL] [Abstract][Full Text] [Related]
38. Biomodulation of Fluorouracil in colorectal cancer. Ardalan B; Luis R; Jaime M; Franceschi D Cancer Invest; 1998; 16(4):237-51. PubMed ID: 9589033 [TBL] [Abstract][Full Text] [Related]
39. A toxicity study of trimetrexate used in combination with cyclosporine as acute graft-versus-host disease prophylaxis in HLA-mismatched, related donor bone marrow transplants. Doney KC; Storb R; Beach K; Anasetti C; Deeg HJ; Hansen JA; Martin PJ; Nash RA; Schubert MM; Sullivan KM Transplantation; 1995 Jul; 60(1):55-8. PubMed ID: 7624943 [TBL] [Abstract][Full Text] [Related]
40. Unexpected acute neurologic toxicity in the treatment of children with acute lymphoblastic leukemia. Winick NJ; Bowman WP; Kamen BA; Roach ES; Rollins N; Jacaruso D; Buchanan GR J Natl Cancer Inst; 1992 Feb; 84(4):252-6. PubMed ID: 1734087 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]